Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea
Authors:
- Klaus KümmererKKKlaus Kümmerer
- 1 October 2011
- journal article
- Published by Elsevier in Chemosphere
- Vol. 85 (5) , 765-773
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The lysosome among targets of metformin: new anti-inflammatory uses for an old drug?Expert Opinion on Therapeutic Targets, 2010
- Antidiabetic drug metformin (Glucophage R ) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcriptionProceedings of the National Academy of Sciences, 2009
- Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?BMJ, 2007
- Pharmacogenetics of metformin response: a step in the path toward personalized medicineJournal of Clinical Investigation, 2007
- Local use of antibiotics and their input and fate in a small sewage treatment plant – significance of balancing and analysis on a local scale vs. nationwide scaleActa Hydrochimica et Hydrobiologica, 2006
- Final Report of the Safety Assessment of Urea1International Journal of Toxicology, 2005
- Radical‐induced oxidation of metforminEuropean Journal of Biochemistry, 2004
- Humanarzneimittel im aquatischen ÖkosystemUmweltwissenschaften und Schadstoff-Forschung, 2004
- Clinical Pharmacokinetics of MetforminClinical Pharmacokinetics, 1996
- Drugs and drug metabolites as environmental contaminants: Chlorophenoxyisobutyrate and salicylic acid in sewage water effluentLife Sciences, 1977